Suppr超能文献

[大众药房计划和巴西国家药物治疗政策中的药品清单]

[The list of drugs in the Popular Pharmacy Program and the Brazilian National Pharmaceutical Care Policy].

作者信息

Yamauti Sueli Miyuki, Barberato-Filho Silvio, Lopes Luciane Cruz

机构信息

Hospital Universitário, Universidade Federal de São Paulo, São Paulo, BR.

Universidade de Sorocaba, Sorocaba, BR.

出版信息

Cad Saude Publica. 2015 Aug;31(8):1648-62. doi: 10.1590/0102-311X00054814.

Abstract

This study aimed to analyze the list of drugs in the Popular Pharmacy Program in Brazil (PFPB) in relation to the country's pharmaceutical care policy. The list of drugs in the PFPB was compared to the Brazilian and international reference lists of essential medicines, the components of pharmaceutical care in Brazilian Unified National Health System (SUS), and drug production by the country's government pharmaceutical laboratories. The PFPB list includes 119 drugs, of which 19.3% and 47.1% were not selected on the Brazilian and international reference lists, respectively; 16.8% are not used in primary care, and 40.3% are not produced by the country's government laboratories. A revision of the PFPB list based on the essential medicines concept (World Health Organization), alignment of pharmaceutical care policies, and production by government laboratories are essential to improve quality of health care, management, training of prescribers, and information for the population.

摘要

本研究旨在分析巴西大众药房计划(PFPB)中的药品清单与该国药学服务政策的关系。将PFPB中的药品清单与巴西和国际基本药物参考清单、巴西统一国家卫生系统(SUS)中药学服务的组成部分以及该国政府制药实验室的药品生产情况进行了比较。PFPB清单包括119种药品,其中分别有19.3%和47.1%未被列入巴西和国际参考清单;16.8%未用于初级保健,40.3%不是由该国政府实验室生产的。根据基本药物概念(世界卫生组织)修订PFPB清单、调整药学服务政策以及政府实验室的生产对于提高医疗保健质量、管理水平、开处方者培训以及为民众提供信息至关重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验